This cross-sectional study analyzes factors associated with the development of CMV-specific CD8þ response, measured by IFNg production after cytomegalovirus (CMV) peptide stimulation, in CMV-seropositive solid organ transplantation candidates. A total of 114 candidates were enrolled, of whom 22.8% (26/114) were nonreactive (IFNg < 0.2 IU/mL). Multivariate logistic regression analysis showed that age, HLA alleles and organ to be transplanted were associated with developing CMV-specific CD8þ immunity (reactive; IFNg ! 0.2 IU/mL). The probability of being reactive was higher in candidates over 50 than in those under 50 (OR 6.33,). Candidates with HLA-A1 and/or HLA-A2 alleles had a higher probability of being reactive than those with non-HLA-A1/non-HLA-A2 alleles (OR 10.97,. Renal candidates had a higher probability of being reactive than lung (adjusted OR 8.85,) and liver candidates (OR 4.87,). The AUC of this model was 0.84 (p < 0.001). Positive and negative predictive values were 84.8% and 76.9%, respectively. In renal candidates longer dialysis was associated with an increased frequency of reactive individuals (p ¼ 0.040). Therefore, although the assessment of CMV-specific CD8þ response is recommended in all Rþ candidates, it is essential in those with a lower probability of being reactive, such as non-renal candidates, candidates under 50 or those with non-HLA-A1/non-HLA-A2 alleles.